Employment
-
Biocon Biologics Ltd Senior Director2017 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (21)
- Biological evaluation of RBx-0128, a potent and selective dipeptidyl peptidase-IV inhibitor in type 2 diabetes genetic model Save
- Antihyperglycemic effect of Annona squamosa hexane extract in type 2 diabetes animal model: PTP1B inhibition, a possible mechanism of action Save
- Erratum: RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes (European Journal of Pharmacology (2011) 652: 1-3 (157-163)) Save
- Nature of action of sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals Save
- From a glucocentric to a lipocentric approach towards metabolic syndrome Save
- Topiramate and Type 2 diabetes: An old wine in a new bottle Save
- Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: Preclinical efficacy and safety in db/db mice Save
- Increase in weight induced by muraglitazar, a dual PPARα/γ agonist, in db/db mice: Adipogenesis/or oedema? Save
- Role of peripheral 5-HT1A receptors in detrusor over activity associated with partial bladder outlet obstruction in female rats Save
- Intermittent claudication: An overview Save